Hansashree Padmanabha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hansashree Padmanabha has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
Pooja Mailankody
Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
14 shared publicationsRohan Mahale
Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India
12 shared publications- Rohan Ramachandra Mahale
Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bangalore, India
7 shared publications - Debjyoti Dhar
Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India
6 shared publications Debjyoti Dhar
Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India
5 shared publicationsGautham Arunachal
Department of Neurogenetics, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
5 shared publications
Latest Publications
- 21 August 2026
- Published by SAGE Publications in Journal of Child Neurology
Neurophysiological Basis of Mirror Movements in Schizencephaly: A Case Report
Mirror movements (MMs) are involuntary movements on one side of the body that mimic voluntary movements on the opposite side. Schizencephaly is an uncommon congenital neuronal migration disorder characterised by the presence of a trans-mantle column of heterotopic grey matter, with or without a full-thickness cleft filled with cerebrospinal fluid, which links the pial surface of the cerebral hemisphere with the ependymal surface of the lateral ventricle. We report a case of a 13-year-old child with unilateral schizencephaly who presented with MMs. Transcranial magnetic stimulation was used to understand the neurophysiology of MMs. Single-pulse and paired-pulse stimulation were done. The silent period was shortened with absent short-interval intracortical inhibition and reduced intracortical facilitation. This suggests reduced GABAergic and glutamatergic transmission in the brain. These altered neurophysiological parameters, along with motor cortex re-organisation, may account for MMs in our case.
- 21 August 2026
- Published by SAGE Publications in Journal of Child Neurology
Neurophysiological Basis of Mirror Movements in Schizencephaly: A Case Report
Mirror movements (MMs) are involuntary movements on one side of the body that mimic voluntary movements on the opposite side. Schizencephaly is an uncommon congenital neuronal migration disorder characterised by the presence of a trans-mantle column of heterotopic grey matter, with or without a full-thickness cleft filled with cerebrospinal fluid, which links the pial surface of the cerebral hemisphere with the ependymal surface of the lateral ventricle. We report a case of a 13-year-old child with unilateral schizencephaly who presented with MMs. Transcranial magnetic stimulation was used to understand the neurophysiology of MMs. Single-pulse and paired-pulse stimulation were done. The silent period was shortened with absent short-interval intracortical inhibition and reduced intracortical facilitation. This suggests reduced GABAergic and glutamatergic transmission in the brain. These altered neurophysiological parameters, along with motor cortex re-organisation, may account for MMs in our case.
- Open Access
- 27 July 2026
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 29 (5) , 875-878
Chronic Meningitis-Like Presentation of Primary Diffuse Leptomeningeal Melanomatosis in a Young Child
Was not provided for this article.
- 27 July 2026
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 29 (5) , 875-878
Open AccessChronic Meningitis-Like Presentation of Primary Diffuse Leptomeningeal Melanomatosis in a Young Child
Was not provided for this article.
- Open Access
- 30 April 2026
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 19 (2) , 192-198
Clinical, Radiological, and Therapeutic Profiles of Patients With DYT-TOR1A: A Single-Center Study in India and Literature Review of the Asian MDSGene Cohort
Clinical, Radiological and Therapeutic Profile of Patients With DYT-TOR1A from a single tertiary care centre in India, with a literature review of the MDSGene Asian cohort
- 30 April 2026
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 19 (2) , 192-198
Open AccessClinical, Radiological, and Therapeutic Profiles of Patients With DYT-TOR1A: A Single-Center Study in India and Literature Review of the Asian MDSGene Cohort
Clinical, Radiological and Therapeutic Profile of Patients With DYT-TOR1A from a single tertiary care centre in India, with a literature review of the MDSGene Asian cohort
- Open Access
- 7 March 2026
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 29 (2) , 299-302
Multiphasic Infarcts in a Young Brain Secondary to Thrombotic Thrombocytopenic Purpura: Looking Beyond the Usual Suspects
An abstract is unavailable. This article is available as a PDF only.
- 7 March 2026
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 29 (2) , 299-302
Open AccessMultiphasic Infarcts in a Young Brain Secondary to Thrombotic Thrombocytopenic Purpura: Looking Beyond the Usual Suspects
An abstract is unavailable. This article is available as a PDF only.
- 8 January 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 135, 28-33
KCTD7-related progressive myoclonic epilepsy: Clinical and genetic characterization of six Indian patients and review of literature
- 8 January 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 135, 28-33
KCTD7-related progressive myoclonic epilepsy: Clinical and genetic characterization of six Indian patients and review of literature
- Open Access
- 7 July 2025
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 15 (1) , 30
VPS16-Associated Dystonia: A Cohort-Based Clinical, Imaging and Genetic Profile
Background: Monoallelic variants in VPS16 are associated with early-onset dystonia (VPS16-associated dystonia) with a frequency of less than 4%. Objective: Description of the clinical, imaging, and genetic profile of VPS16-associated dystonia and comparison of the findings of the Indian cohort with that of the Chinese and European cohorts. Methods: Report of a single patient with VPS16-associated dystonia and review of reported cases of genetically confirmed DYT-VPS16 since 2016 from Indian, Chinese and European cohorts. Results: There were a total of 3 cases from India, 10 cases from China, and 34 cases from Europe. The median age at onset was similar in all cohorts. The median duration of disease was 26 years in the European cohort but a shorter duration was noted in the Indian and Chinese cohorts (13–14 years). Dystonia was the common symptom observed in all cohorts with associated myoclonus, intellectual disability, and psychiatric symptoms commonly reported from European cohort. The onset of dystonia was primarily noticed in the limb/cervical region in all cohorts. Partial to good response to globus pallidus interna deep brain stimulation (DBS) was reported from the European cohort. Brain magnetic resonance imaging was usually normal in all the cohorts. Frameshift and stop-gain variants were common in the European and Indian cohorts, whereas missense variants were common in the Chinese group. Segmental dystonia was common in frameshift variants (70%) and generalized dystonia in stop-gain variants. Conclusion: Our study showed geographically diverse differences in the phenotypic presentation of VPS16-associated dystonia as myoclonus, intellectual disability, and psychiatric symptoms were more common in the European cohort. Segmental dystonia was commonly observed in the frameshift variants and generalized dystonia in stop-gain variants. Highlights VPS16-associated dystonia is a new genetically mediated dystonic syndrome. The clinical presentation is heterogeneous in terms of intrafamilial and interfamilial variability of age at onset and severity of dystonia. We aimed to study the ethnic phenotypic and genotypic differences of VPS16-associated dystonia. Our study showed geographically-diverse differences in the phenotypic presentation as myoclonus, intellectual disability, and psychiatric symptoms were more common in the European cohort. Patients with frameshift variants had segmental dystonia, whereas those with stop-gain variants had generalised dystonia.
- 7 July 2025
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 15 (1) , 30
Open AccessVPS16-Associated Dystonia: A Cohort-Based Clinical, Imaging and Genetic Profile
Background: Monoallelic variants in VPS16 are associated with early-onset dystonia (VPS16-associated dystonia) with a frequency of less than 4%. Objective: Description of the clinical, imaging, and genetic profile of VPS16-associated dystonia and comparison of the findings of the Indian cohort with that of the Chinese and European cohorts. Methods: Report of a single patient with VPS16-associated dystonia and review of reported cases of genetically confirmed DYT-VPS16 since 2016 from Indian, Chinese and European cohorts. Results: There were a total of 3 cases from India, 10 cases from China, and 34 cases from Europe. The median age at onset was similar in all cohorts. The median duration of disease was 26 years in the European cohort but a shorter duration was noted in the Indian and Chinese cohorts (13–14 years). Dystonia was the common symptom observed in all cohorts with associated myoclonus, intellectual disability, and psychiatric symptoms commonly reported from European cohort. The onset of dystonia was primarily noticed in the limb/cervical region in all cohorts. Partial to good response to globus pallidus interna deep brain stimulation (DBS) was reported from the European cohort. Brain magnetic resonance imaging was usually normal in all the cohorts. Frameshift and stop-gain variants were common in the European and Indian cohorts, whereas missense variants were common in the Chinese group. Segmental dystonia was common in frameshift variants (70%) and generalized dystonia in stop-gain variants. Conclusion: Our study showed geographically diverse differences in the phenotypic presentation of VPS16-associated dystonia as myoclonus, intellectual disability, and psychiatric symptoms were more common in the European cohort. Segmental dystonia was commonly observed in the frameshift variants and generalized dystonia in stop-gain variants. Highlights VPS16-associated dystonia is a new genetically mediated dystonic syndrome. The clinical presentation is heterogeneous in terms of intrafamilial and interfamilial variability of age at onset and severity of dystonia. We aimed to study the ethnic phenotypic and genotypic differences of VPS16-associated dystonia. Our study showed geographically-diverse differences in the phenotypic presentation as myoclonus, intellectual disability, and psychiatric symptoms were more common in the European cohort. Patients with frameshift variants had segmental dystonia, whereas those with stop-gain variants had generalised dystonia.
- 18 June 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 137, 107930
SLC18A2 associated infantile-onset- parkinsonism-dystonia 2: A novel genotype
- 18 June 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 137, 107930
SLC18A2 associated infantile-onset- parkinsonism-dystonia 2: A novel genotype
- 15 April 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (4) , 1-12
Targeted metabolomics in children with autism spectrum disorder with and without developmental regression
Early diagnosis and intervention in children with autism spectrum disorder (ASD) is crucial. At present, diagnosis of ASD is primarily based on subjective tools. Identifying metabolic biomarkers will aid in early diagnosis of ASD complementing the assessment tools. The study aimed to conduct targeted metabolomic analysis and determine the plasma metabolites that can discriminate children with ASD from typically developing children (TD), and to determine the utility of machine learning in classifying ASD children based on the metabotypes. This was a multi-centric, analytical, case-control study conducted between April 2021–April 2023. Fasting plasma samples were obtained from seventy ASD and fifty-eight TD children, aged 2 to 12 years. Samples were quantitively analysed for 52 targeted metabolites (13 amino acids, 37 acylcarnitines, adenosine and 2-deoxyadenosine levels) using tandem mass spectrometry. An in-depth statistical analysis was performed. A total of 26 metabolites (11 amino acids, 14 acyl carnitines and adenosine) were found to be significantly (p < 0.005) different between ASD and TD children. Adenosine and amino acid levels were significantly decreased in ASD children. Among acyl carnitines, short- and long-chain acyl carnitine levels were significantly decreased, while medium-chain acyl carnitine levels were significantly increased in ASD children. Octenoylcarnitine-C8:1 (Cut-off value- 0.025 mmol/L, AUC- 0.683) and adenosine (Cut-off value- 0.025 mmol/L, AUC- 0.673) were found to predict children with ASD at a sensitivity of 55.7% and 57.1%, specificity of 79.3% and 72.4% respectively. Based on the metabolites, machine learning models like Support Vector Machine (SVM) and Random Forest (RF) were able to discriminate ASD from TD children with the classification accuracy score being highest in RF (79.487%, AUC- 0.800). Significant abnormalities in plasma metabolites were observed leading to disturbances in the Krebs cycle, urea cycle and fatty acid oxidation, suggesting mitochondrial dysfunction that may possibly contribute in the pathobiology of ASD. Octenoylcarnitine-C8:1 and Adenosine may serve as potential metabolic biomarkers for ASD.
- 15 April 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (4) , 1-12
Targeted metabolomics in children with autism spectrum disorder with and without developmental regression
Early diagnosis and intervention in children with autism spectrum disorder (ASD) is crucial. At present, diagnosis of ASD is primarily based on subjective tools. Identifying metabolic biomarkers will aid in early diagnosis of ASD complementing the assessment tools. The study aimed to conduct targeted metabolomic analysis and determine the plasma metabolites that can discriminate children with ASD from typically developing children (TD), and to determine the utility of machine learning in classifying ASD children based on the metabotypes. This was a multi-centric, analytical, case-control study conducted between April 2021–April 2023. Fasting plasma samples were obtained from seventy ASD and fifty-eight TD children, aged 2 to 12 years. Samples were quantitively analysed for 52 targeted metabolites (13 amino acids, 37 acylcarnitines, adenosine and 2-deoxyadenosine levels) using tandem mass spectrometry. An in-depth statistical analysis was performed. A total of 26 metabolites (11 amino acids, 14 acyl carnitines and adenosine) were found to be significantly (p < 0.005) different between ASD and TD children. Adenosine and amino acid levels were significantly decreased in ASD children. Among acyl carnitines, short- and long-chain acyl carnitine levels were significantly decreased, while medium-chain acyl carnitine levels were significantly increased in ASD children. Octenoylcarnitine-C8:1 (Cut-off value- 0.025 mmol/L, AUC- 0.683) and adenosine (Cut-off value- 0.025 mmol/L, AUC- 0.673) were found to predict children with ASD at a sensitivity of 55.7% and 57.1%, specificity of 79.3% and 72.4% respectively. Based on the metabolites, machine learning models like Support Vector Machine (SVM) and Random Forest (RF) were able to discriminate ASD from TD children with the classification accuracy score being highest in RF (79.487%, AUC- 0.800). Significant abnormalities in plasma metabolites were observed leading to disturbances in the Krebs cycle, urea cycle and fatty acid oxidation, suggesting mitochondrial dysfunction that may possibly contribute in the pathobiology of ASD. Octenoylcarnitine-C8:1 and Adenosine may serve as potential metabolic biomarkers for ASD.
- 27 March 2025
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (8) , 3827-3838
CSF1R-related disorder: A clinical, imaging and genetic profile review
Background Colony-stimulating factor 1 receptor (CSF1R) -related disorder (CSF1R-RD) is a primary microgliopathy with a distinct clinical, imaging and genetic profile. Objective Description of the clinical, imaging and genetic profile of CSF1R-RD and comparison of Indian cohort with Asian, European and American cohort. Methods Report of 2 cases of CSF1R-RD and review of reported cases of genetically confirmed CSF1R-RD since 2012 from Indian, Asian, European and American cohorts. Results Two patients were females with age at onset at 40 and 42 years. The duration of symptoms was 2 and 5 years. Both had spasticity, cognitive impairment and psychiatric disturbances. Brain imaging showed hyperintensities in the cerebral white mater involving deep and periventricular white mater with diffusion restriction in one patient. There was diffuse cerebral and corpus callosum atrophy. Genetics showed heterozygous missense variants in exon 18 of the CSF1R gene in both patients. The Indian cohort of 5 patients had additional symptoms of dysarthria, dysphagia, parkinsonism, tremor and gait abnormality, similar radiological features. The Asian, European and American cohort had similar clinical and radiological features. Seizures were more commonly reported in America cohort and presence of calcification was less common imaging abnormality in all cohorts. Genetic profiling showed heterozygous predominantly missense variants in the TKD in all cohorts. Conclusion CSF1R-RD has distinct clinical profile of cognitive impairment, spasticity, psychiatric disturbances with dysarthria, dysphagia, parkinsonism, tremor, ataxia, seizures, aphasia and gait abnormality. Calcification is less common radiological abnormality with heterozygous missense variants in the TKD as the common genetic variant.
- 27 March 2025
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (8) , 3827-3838
CSF1R-related disorder: A clinical, imaging and genetic profile review
Background Colony-stimulating factor 1 receptor (CSF1R) -related disorder (CSF1R-RD) is a primary microgliopathy with a distinct clinical, imaging and genetic profile. Objective Description of the clinical, imaging and genetic profile of CSF1R-RD and comparison of Indian cohort with Asian, European and American cohort. Methods Report of 2 cases of CSF1R-RD and review of reported cases of genetically confirmed CSF1R-RD since 2012 from Indian, Asian, European and American cohorts. Results Two patients were females with age at onset at 40 and 42 years. The duration of symptoms was 2 and 5 years. Both had spasticity, cognitive impairment and psychiatric disturbances. Brain imaging showed hyperintensities in the cerebral white mater involving deep and periventricular white mater with diffusion restriction in one patient. There was diffuse cerebral and corpus callosum atrophy. Genetics showed heterozygous missense variants in exon 18 of the CSF1R gene in both patients. The Indian cohort of 5 patients had additional symptoms of dysarthria, dysphagia, parkinsonism, tremor and gait abnormality, similar radiological features. The Asian, European and American cohort had similar clinical and radiological features. Seizures were more commonly reported in America cohort and presence of calcification was less common imaging abnormality in all cohorts. Genetic profiling showed heterozygous predominantly missense variants in the TKD in all cohorts. Conclusion CSF1R-RD has distinct clinical profile of cognitive impairment, spasticity, psychiatric disturbances with dysarthria, dysphagia, parkinsonism, tremor, ataxia, seizures, aphasia and gait abnormality. Calcification is less common radiological abnormality with heterozygous missense variants in the TKD as the common genetic variant.